open access

Vol 75, No 7 (2017)
State-of-the-art review
Published online: 2017-04-11
Submitted: 2017-03-18
Accepted: 2017-03-28
Get Citation

Risk assessment in patients with ST elevation myocardial infarction treated with primary percutaneous coronary angioplasty. Does reduced duration of hospital stay affect the prognosis?

Marcin Dębiński, Marek Kondys, Paweł E. Buszman
DOI: 10.5603/KP.a2017.0076
·
Kardiol Pol 2017;75(7):635-640.

open access

Vol 75, No 7 (2017)
State-of-the-art review
Published online: 2017-04-11
Submitted: 2017-03-18
Accepted: 2017-03-28

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Risk assessment in patients with ST elevation myocardial infarction treated with primary percutaneous coronary angioplasty. Does reduced duration of hospital stay affect the prognosis?

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 75, No 7 (2017)

Pages

635-640

Published online

2017-04-11

DOI

10.5603/KP.a2017.0076

Bibliographic record

Kardiol Pol 2017;75(7):635-640.

Authors

Marcin Dębiński
Marek Kondys
Paweł E. Buszman

References (25)
  1. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006; 27(19): 2285–2293.
  2. Fox KAA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006; 333(7578): 1091.
  3. Fox KAA, Carruthers KF, Dunbar DR, et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur Heart J. 2010; 31(22): 2755–2764.
  4. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000; 102(17): 2031–2037.
  5. Fox KAA, Anderson FA, Dabbous OH, et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart. 2007; 93(2): 177–182.
  6. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation. 1995; 91(6): 1659–1668.
  7. Grines CL, Marsalese DL, Brodie B, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol. 1998; 31(5): 967–972.
  8. De Luca G, Suryapranata H, van 't Hof AWJ, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation. 2004; 109(22): 2737–2743.
  9. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993; 270(10): 1211–1216.
  10. Taher T, Fu Y, Wagner G, et al. Aborted myocardial infarction in patients with ST-segment elevation. J Am Coll Cardiol. 2004; 44(1): 38–43.
  11. Lamfers EJ, Hooghoudt TE, Uppelschoten A, et al. Effect of prehospital thrombolysis on aborting acute myocardial infarction. Am J Cardiol. 1999; 84(8): 928–30, A6.
  12. Lamfers EJP, Hooghoudt TEH, Hertzberger DP, et al. Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis. Heart. 2003; 89(5): 496–501.
  13. Thygesen K, Alpert JS, Jaffe AS, et al. Third Universal Definition of Myocardial Infarction. Circulation. 2012; 126(16): 2020–2035.
  14. Steg PhG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2012; 33(20): 2569–2619.
  15. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014; 35(37): 2541–2619.
  16. Szymański RJ, Kiesz RS, Wiernek SŁ, et al. Utilisation of bivalirudin and vascular closure devices for same-day discharge after percutaneous coronary and peripheral interventions. Kardiol Pol. 2016; 74(6): 553–560.
  17. Kiesz RS, Wiernek BK, Wiernek SL, et al. Cardiva Catalyst II vascular access management device in percutaneous diagnostic and interventional procedures with same-day discharge (Catalyst II trial). J Endovasc Ther. 2011; 18(1): 46–53.
  18. Termin-Pośpiech A, Buszman P, Tendera M. [Procedures of invasive cardiology performed in ambulatory care]. Kardiol Pol. 2005; 62(2): 157–160.
  19. Termin-Pośpiech A. Ocena wczesnych i odległych wyników zabiegów kardiologii inwazyjnej wykonywanych na bazie krótkiej hospitalizacji. Doctor thesis SUM Katowice, 2012. Thesis supervisor Buszman P.
  20. Spencer FA, Lessard D, Gore JM, et al. Declining length of hospital stay for acute myocardial infarction and postdischarge outcomes: a community-wide perspective. Arch Intern Med. 2004; 164(7): 733–740.
  21. Berger AK, Duval S, Jacobs DR, et al. Relation of length of hospital stay in acute myocardial infarction to postdischarge mortality. Am J Cardiol. 2008; 101(4): 428–434.
  22. Chin CT, Weintraub WS, Dai D, et al. Trends and predictors of length of stay after primary percutaneous coronary intervention: a report from the CathPCI registry. Am Heart J. 2011; 162(6): 1052–1061.
  23. Kotowycz MA, Cosman TL, Tartaglia C, et al. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial). Am Heart J. 2010; 159(1): 117.e1–117.e6.
  24. Agarwal S, Parashar A, Garg A, et al. Length of stay and long-term mortality following ST elevation myocardial infarction. Catheter Cardiovasc Interv. 2015; 86 Suppl 1: S1–S7.
  25. Jones DA, Rathod KS, Howard JP, et al. Safety and feasibility of hospital discharge 2 days following primary percutaneous intervention for ST-segment elevation myocardial infarction. Heart. 2012; 98(23): 1722–1727.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl